Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2008
11/13/2008US20080282430 Expression vector comprising nucleotide sequences coding proteins for use in generation of drought, cold, freeze, heat and salt resistant crops
11/13/2008US20080282427 Expression vector comprising nucleotide sequences coding diacylglycerol acyltransferase for use in generation of transgenic crops with enhanced ricinoleic acid biosynthesis
11/13/2008US20080282363 Methods for producing human antibodies in scid mice
11/13/2008US20080281082 Humanized antibodies that recognize beta amyloid peptide
11/13/2008US20080280833 amino acid motif GAAG; polypeptide that inhibits cell migration, cell adhesion, cell proliferation and/or cell differentiation; anticancer; adenocarcinoma, leukemia, lymphoma, or myeloma; inhibitor of chemotaxis
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280818 Glycosylation of peptides via o-linked glycosylation sequences
11/13/2008US20080280356 Expression vector for use as transformation and gene transfer agent
11/13/2008US20080280346 System For the Production of Dimeric Proteins Based on the Transport System of Hemolysin of Escherichia Coli
11/13/2008US20080280327 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases
11/13/2008US20080280322 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells
11/13/2008US20080280321 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/13/2008US20080280309 Monoclonal antibodies and uses thereof
11/13/2008US20080280301 Using transmembrane serine protease expression as evaluative tool in detection of nervous system stem cells; regenerative medicine; tissue engineering; treating neurodegenerative
11/13/2008US20080280297 Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia
11/13/2008US20080280288 Assay Method to Predict Sensitivity of Cancer Cell to Anticancer Drug
11/13/2008US20080280281 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
11/13/2008US20080279919 Liposomes for protection against toxic compounds
11/13/2008US20080279874 Compositions and methods for modulation of plk1 kinase activity
11/13/2008US20080279873 Active immunization to generate antibodies to soluble a-beta
11/13/2008US20080279872 Using dendritic cells expressing chymotrypsin protein fragment as immunostimulatory tool for targeting cancer cells associated with ovarian tissue
11/13/2008US20080279862 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders
11/13/2008US20080279860 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of metastatic ovarian cancer; immunotherapy
11/13/2008US20080279859 Neurite outgrowth inhibitor -66 receptor (NOGO-66) specific monoclonal antibody for treatment and prevention of nervous system, muscular, tumor and vision disorders
11/13/2008US20080279858 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
11/13/2008US20080279857 Therapeutic Agent
11/13/2008US20080279854 Tumor suppressor antigen (5T4) for use as therapeutic tool in treatment and prevention of cell proliferative disorders
11/13/2008US20080279852 Methods of treatment with glycosylated antibodies
11/13/2008US20080279851 Type I transmembrane protein specific immunoglobulin for treatment and prevention of cell proliferative and inflammatory disorders
11/13/2008US20080279850 Tetraspanin specific immunoglobulin for use in the treatment and prevention of non-burkitt's malignancy
11/13/2008US20080279847 Tumor-associated glycoprotein-72 specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
11/13/2008US20080279772 Generation of therapeutic radioconjugate; load isotope onto binding support, elute long lived isotopes, join isotope to targeting particle, recover radioconjugate
11/13/2008US20080279767 Cancerous disease modifying antibodies
11/13/2008CA2686861A1 Interferon alpha-induced pharmacodynamic markers
11/13/2008CA2685954A1 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
11/13/2008CA2685805A1 Klebsiella antigens
11/13/2008CA2685698A1 Anti-tissue factor antibodies and compositions with enhanced effector function
11/13/2008CA2685675A1 Immunoglobulin fc libraries
11/13/2008CA2685213A1 Engineered rabbit antibody variable domains and uses thereof
11/13/2008CA2684906A1 Cancerous disease modifying antibodies
11/13/2008CA2682835A1 Crig antagonists
11/13/2008CA2666179A1 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
11/12/2008EP1990415A1 Osteoprotegerin
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990409A2 Bacteriophage
11/12/2008EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment
11/12/2008EP1990057A1 Beta-secretase substrates and uses thereof
11/12/2008EP1989328A2 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
11/12/2008EP1989308A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases
11/12/2008EP1989233A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
11/12/2008EP1989232A1 Cytotoxicity mediation of cells evidencing surface expression of cd59
11/12/2008EP1989231A2 Combinatorial therapy involving alpha5beta1 antagonists
11/12/2008EP1989230A2 Anti-fgf19 antibodies and methods using same
11/12/2008EP1989229A1 Binding molecules
11/12/2008EP1988922A2 Protein formulations
11/12/2008EP1988921A2 Methods of treating inflammatory and autoimmune diseases with natalizumab
11/12/2008EP1988882A2 Prolongation of survival of an allograft by inhibiting complement activity
11/12/2008EP1988768A2 Gene disruptions, compositions and methods relating thereto
11/12/2008EP1682582A4 Method for the mass production of immunoglobulin constant region
11/12/2008EP1639011B1 Pegylated single domain antibodies (dAb)
11/12/2008EP1561759B1 Cell death-inducing agent
11/12/2008EP1478738B1 Anti-ccr5 antibody
11/12/2008EP1395275B1 Beta-secretase substrate and uses thereof
11/12/2008EP1259615B1 Antibodies against eotaxin and their use
11/12/2008EP1232184B1 Antibody against the human toll-like receptor-2 (tlr2) and uses thereof
11/12/2008EP1064551B1 Development of human monoclonal antibodies and uses thereof
11/12/2008EP0950103B1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
11/12/2008EP0792359B1 Transcription factor e2f-4
11/12/2008EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
11/12/2008CN101305093A Method for stabilization of biological molecule and composition
11/12/2008CN101305021A Compositions and methods for diagnosing and treating an inflammation
11/12/2008CN101305020A Identification of tumor-associated antigens for diagnosis and therapy
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302254A Monoclonal antibody of hepatoma-derived growth factor and use thereof
11/12/2008CN101302253A Monoclonal antibody of mycobacterium tuberculosis secretory protein desA and use thereof in tuberculosis serological diagnosis
11/12/2008CN100432671C Detection of microorganisms in liquid hydrocarbon fuel
11/12/2008CN100432217C Process for the production of biological substances by perfusion culturing of suspended animal cells
11/12/2008CN100432105C Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2
11/12/2008CN100432103C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells.
11/12/2008CN100432096C Transfer factor specific for SARS virus and method for preparing same
11/11/2008US7449623 Nucleic acid molecules from rice and their use for the production of modified starch
11/11/2008US7449616 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy
11/11/2008US7449560 Phosophoinositoglycan binding proteins
11/11/2008US7449559 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states
11/11/2008US7449556 genetic engineered antibody fragment having preferential binding for RNA virus epitopes, with variable light or heavy chain domains;immunology; veternary medicine
11/11/2008US7449555 Antibodies of angiogenesis inhibiting domains CD148
11/11/2008US7449554 Antibodies against the PRO4977 polypeptides
11/11/2008US7449553 Lipid engineering for analyzing a structure, or functions of a ceramide, diseases associated with the ceramide metabolism; controlling an amount of ceramide in a cell
11/11/2008US7449551 PRO211 polypeptides
11/11/2008US7449549 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
11/11/2008US7449548 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
11/11/2008US7449543 Binds to the polypeptide g34872 or binds to a calcium/calmodulin-dependent kinase II; treatment or diagnosis of central nervous system and bipolar disorders
11/11/2008US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/11/2008US7449445 Conductive peptide nanofiber and method of manufacture of the same
11/11/2008US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus)
11/11/2008US7449321 Controlling a flavivirus entry into a cell by administering to the cell an agent functionally interfering with a flavivirus receptor protein, the flavivirus receptor protein being an integrin
11/11/2008US7449316 UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, α4Gal-T1
11/11/2008US7449315 Bifunctional energy-reversible acyl-compositions
11/11/2008US7449309 administering antibodies or fragments that binds to kit proteins (glycoprotein receptor protein-tyrosine kinase), to inhibit the kinase enzymatic reactions and to inhibit the stem cell factor signal transduction; treatment of skin disorders, asthma, inflammation, anaphylaxis, bronchospasm and tumors
11/11/2008US7449303 Use of JAG2 expression in diagnosis of plasma cell disorders
1 ... 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 ... 1494